|
|
|
|
|
|
最高研发阶段临床1期 |
首次获批国家/地区- |
首次获批日期- |
ST-605 uncontrolled open-label phase 2 study in patients with herpes simplex virus keratitis
ST-605 phase 2 study - uncontrolled open-label study in patients with cytomegalovirus corneal endotheliitis -
A Randomized, Double-Blind, Placebo-Controlled, Ascending Dose, Phase IIa Study of Safety and Motor Function Restoration in Subjects Treated With SA4503 Following Acute Ischemic Stroke
The purpose of this study is to evaluate the safety and tolerability of SA4503 in patients recovering from a recent stroke. Secondary, to evaluate the efficacy of SA4503 compared to placebo.
100 项与 M's Science Corp. 相关的临床结果
0 项与 M's Science Corp. 相关的专利(医药)
100 项与 M's Science Corp. 相关的药物交易
100 项与 M's Science Corp. 相关的转化医学